A New Treatment Strategy for BRCA1-Related Breast Cancer

2021 ◽  
pp. 107-115
Author(s):  
Jose Russo
Keyword(s):  
Breast Cancer ◽  
Treatment Strategy ◽  
New Treatment

New treatment strategy for bone metastases from breast cancer

Breast Cancer ◽  
1999 ◽  
Vol 6 (4) ◽  
pp. 292-297 ◽  
Author(s):  
Norio Kohno ◽  
Sohei Kitazawa ◽  
Muneharu Konishi ◽  
Kazuyuki Wakita ◽  
Yoshihiko Furuya ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Metastases ◽  
Treatment Strategy ◽  
New Treatment

scholarly journals Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer

2019 ◽  
Vol 177 (2) ◽  
pp. 369-382 ◽  
Author(s):  
Vladislav Korobeynikov ◽  
Michelle Borakove ◽  
Yayi Feng ◽  
William M. Wuest ◽  
Alex B. Koval ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Treatment Strategy ◽  
Aurora A ◽  
New Treatment ◽  
P21 Activated Kinase

Pemetrexed: A promising new treatment for breast cancer

2002 ◽  
Vol 29 (2 Suppl 5) ◽  
pp. 36-41 ◽  
Author(s):  
Joyce A. O'Shaughnessy ◽  
Alessandra Gennari ◽  
PierFranco Conte
Keyword(s):  
Breast Cancer ◽  
New Treatment

Immunotherapy: New insights in breast cancer treatment

2021 ◽  
pp. 1-10
Author(s):  
Bader Alshehri
Keyword(s):  
Breast Cancer ◽  
Immune Response ◽  
Immune System ◽  
Cancer Treatment ◽  
Immune Evasion ◽  
Breast Tumor ◽  
Parp Inhibitor ◽  
Breast Cancer Treatment ◽  
New Treatment

Breast cancer being the most malignant and lethal disease persistent among women globally. Immunotherapy as a new treatment modality has emerged in understanding the loopholes in the treatment of breast cancer which is mainly attributed to the potential of tumor cells to evade and survive the immune response by developing various strategies. Therefore, improved understanding of the immune evasion by cancer cells and the monoclonal antibodies against PD- and PD-L1 can help us in the diagnosis of this malignancy. Here in this article, I have highlighted that in addition to focusing on other strategies for breast cancer treatment, the involvement of immune system in breast cancer is vital for the understanding of this malignancy. Further, the complete involvement of immune system in the relapse or recurrence of the breast tumor and have also highlighted the role of vaccines, PD-1 and CTLA-4 with the recent advances in the field. Moreover, in addition to the application of immunotherapy as a sole therapy, combinations of immunotherapy with various strategies like targeting it with MEK inhibitors, Vaccines, chemotherapy and PARP inhibitor has shown to have significant benefits is also discussed in this article.

scholarly journals Treatment strategy for locally advanced breast cancer in our department

The Breast ◽  
2021 ◽  
Vol 56 ◽  
pp. S43
Author(s):  
H. Komatsu ◽  
K. Ishida ◽  
Y. Matsui ◽  
S. Amano ◽  
M. Hashimoto ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Treatment Strategy ◽  
Locally Advanced Breast Cancer ◽  
Locally Advanced ◽  
Advanced Breast
Sign in / Sign up

Export Citation Format

Share Document